Effects of oral iron supplement on breath-holding spells in children
Journal Title: Iranian Journal of Child Neurology - Year 2006, Vol 1, Issue 1
Abstract
Objectives: Breath holding spells are one of the most frequent and important diagnostic challenges in pediatrics. The aim of this study, conducted on pediatric patients referring to the pediatric neurology clinic in Hormozgan province, was to evaluate therapeutic effects of iron on breath holding spells Materials and Methods: 35 children (19 males and 16 females), aged between 3 to 60 months, with a history of breath-holding spells, were included in the trial. To obtain all relevant data a specifically designed questionnaire requiring information on sex, age, age of onset of spells, type of spells, frequency of attacks before and after treatment with oral iron supplement, and determinants of body iron stores was completed for all the patients, based on the mother’s statements. The patients were treated by an oral iron preparation for three months. Results: The age of onset of spells ranged between 6 to 24 months. The cyanotic type of spell was detected in 31 children, the pallid type in 3, and the mixed type in one child. There were 14 children with iron deficiency anemia and 20 children with reduced iron stores. Just one child had a normal iron profile. Complete therapeutic response was documented in 24 children, good response in 9, and poor response in one and in one child no change in frequency of spells was seen. Conclusion: Although no significant therapeutic difference was seen in the different response groups, it seems that iron supplement may play an important role in reducing breath holding spells in children. Keywords: Iron, Breath holding spell, children, Iron deficiency Anemia
Authors and Affiliations
S. Tonekaboni, S. Alavi, F. Mahavelati, Z. Tabasi
High and Low dose IVIG therapy in GBS children: A comparison<br />
Introduction: Acute inflammatory demyelinating peripheral neuropathy (Guillain-Barre-Syndrome) is by far the most common cause of immune-medicated peripheral nervous system disease in children; with the near disappeara...
Febrile Seizure: Recurrence and Risk Factors<br />
Background: Febrile Convulsion is the most common convulsive disorder in children, occurring in 2 to 4% of the pediatric population and recurring in 30-50% of cases. Considering the varying recurrence rates reported, t...
Antiepileptic drug therapy and serum carnitine levels in children prior to and following treatment.<br />
Background: The physiologic function of carnitine, oxidation of fatty acid and lipid metabolism, is severely affected in carnitine deficiency, secondary forms of which lead to renal tubular disorders and chronic renal f...
THE EFFECT OF ANTICONVULSANT DRUGS (PHENOBARBITAL AND VALPROIC ACID) ON THE SERUM LEVEL OF CHOLESTEROL, TRIGLYCERIDE, LIPOPROTEIN AND LIVER ENZYMES IN CONVULSIVE CHILDREN
[url=http://journals.sbmu.ac.ir/ijcn/article/view/2006]journals.sbmu.ac.ir/ijcn/article/view/2006[/url]
Vitamin B6 & treatment of infantile spasms: a comparison with standard steroid therapy<br />
Background: Considering the inadequacies of current therapeutic regimens for infantile spasms (IS), and the frequent and serious side effects of these regimens, the ongoing search for more enhanced protocols is understan...